NORATIS AG (NUVA.DE) Fundamental Analysis & Valuation

FRA:NUVA • DE000A2E4MK4

Current stock price

0.181 EUR
-0.02 (-9.5%)
Last:

This NUVA.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. NUVA.DE Profitability Analysis

1.1 Basic Checks

  • In the past year NUVA has reported negative net income.
  • In the past year NUVA had a positive cash flow from operations.
  • In multiple years NUVA reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: NUVA reported negative operating cash flow in multiple years.
NUVA.DE Yearly Net Income VS EBIT VS OCF VS FCFNUVA.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

  • NUVA has a worse Return On Assets (-5.16%) than 66.22% of its industry peers.
  • With a Return On Equity value of -38.04%, NUVA is not doing good in the industry: 72.97% of the companies in the same industry are doing better.
  • The Return On Invested Capital of NUVA (0.71%) is comparable to the rest of the industry.
  • NUVA had an Average Return On Invested Capital over the past 3 years of 1.90%. This is below the industry average of 4.09%.
Industry RankSector Rank
ROA -5.16%
ROE -38.04%
ROIC 0.71%
ROA(3y)-2.47%
ROA(5y)-0.91%
ROE(3y)-16.73%
ROE(5y)-6.94%
ROIC(3y)1.9%
ROIC(5y)2.12%
NUVA.DE Yearly ROA, ROE, ROICNUVA.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

1.3 Margins

  • NUVA's Operating Margin of 4.65% is in line compared to the rest of the industry. NUVA outperforms 50.00% of its industry peers.
  • NUVA's Operating Margin has declined in the last couple of years.
  • With a Gross Margin value of 17.76%, NUVA perfoms like the industry average, outperforming 44.59% of the companies in the same industry.
  • In the last couple of years the Gross Margin of NUVA has declined.
Industry RankSector Rank
OM 4.65%
PM (TTM) N/A
GM 17.76%
OM growth 3Y-20.54%
OM growth 5Y-12.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.05%
GM growth 5Y-6.76%
NUVA.DE Yearly Profit, Operating, Gross MarginsNUVA.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

3

2. NUVA.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NUVA is destroying value.
  • Compared to 1 year ago, NUVA has more shares outstanding
  • NUVA has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for NUVA is higher compared to a year ago.
NUVA.DE Yearly Shares OutstandingNUVA.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
NUVA.DE Yearly Total Debt VS Total AssetsNUVA.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • Based on the Altman-Z score of 1.02, we must say that NUVA is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of NUVA (1.02) is comparable to the rest of the industry.
  • The Debt to FCF ratio of NUVA is 9.27, which is on the high side as it means it would take NUVA, 9.27 years of fcf income to pay off all of its debts.
  • NUVA's Debt to FCF ratio of 9.27 is fine compared to the rest of the industry. NUVA outperforms 75.68% of its industry peers.
  • NUVA has a Debt/Equity ratio of 4.80. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 4.80, NUVA is not doing good in the industry: 78.38% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 4.8
Debt/FCF 9.27
Altman-Z 1.02
ROIC/WACC0.21
WACC3.36%
NUVA.DE Yearly LT Debt VS Equity VS FCFNUVA.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 4.49 indicates that NUVA has no problem at all paying its short term obligations.
  • NUVA has a better Current ratio (4.49) than 85.14% of its industry peers.
  • A Quick Ratio of 0.19 indicates that NUVA may have some problems paying its short term obligations.
  • The Quick ratio of NUVA (0.19) is worse than 77.03% of its industry peers.
Industry RankSector Rank
Current Ratio 4.49
Quick Ratio 0.19
NUVA.DE Yearly Current Assets VS Current LiabilitesNUVA.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

4

3. NUVA.DE Growth Analysis

3.1 Past

  • NUVA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 52.39%, which is quite impressive.
  • NUVA shows a strong growth in Revenue. In the last year, the Revenue has grown by 43.83%.
  • NUVA shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.61% yearly.
EPS 1Y (TTM)52.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.45%
Revenue 1Y (TTM)43.83%
Revenue growth 3Y-3.3%
Revenue growth 5Y-2.61%
Sales Q2Q%8.18%

3.2 Future

  • NUVA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.63% yearly.
  • NUVA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.38% yearly.
EPS Next Y48.11%
EPS Next 2Y41.51%
EPS Next 3Y26.7%
EPS Next 5Y15.63%
Revenue Next Year-29.11%
Revenue Next 2Y8.43%
Revenue Next 3Y10.31%
Revenue Next 5Y9.38%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NUVA.DE Yearly Revenue VS EstimatesNUVA.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 20M 40M 60M 80M
NUVA.DE Yearly EPS VS EstimatesNUVA.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2 -4

5

4. NUVA.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • NUVA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • A Price/Forward Earnings ratio of 17.75 indicates a rather expensive valuation of NUVA.
  • NUVA's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. NUVA is cheaper than 64.86% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 23.54. NUVA is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 17.75
NUVA.DE Price Earnings VS Forward Price EarningsNUVA.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as NUVA.
  • Based on the Price/Free Cash Flow ratio, NUVA is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.07
EV/EBITDA 92.58
NUVA.DE Per share dataNUVA.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

  • NUVA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as NUVA's earnings are expected to grow with 26.70% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.51%
EPS Next 3Y26.7%

0

5. NUVA.DE Dividend Analysis

5.1 Amount

  • NUVA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

NUVA.DE Fundamentals: All Metrics, Ratios and Statistics

NORATIS AG

FRA:NUVA (3/5/2026, 7:00:00 PM)

0.181

-0.02 (-9.5%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)10-02
Earnings (Next)07-09
Inst Owners0.14%
Inst Owner ChangeN/A
Ins Owners0.7%
Ins Owner ChangeN/A
Market Cap2.46M
Revenue(TTM)68.25M
Net Income(TTM)-20.73M
Analysts42.22
Price Target1.12 (518.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 17.75
P/S 0.04
P/FCF 0.07
P/OCF 0.07
P/B 0.05
P/tB 0.05
EV/EBITDA 92.58
EPS(TTM)-2.02
EYN/A
EPS(NY)0.01
Fwd EY5.64%
FCF(TTM)2.74
FCFY1513.09%
OCF(TTM)2.74
OCFY1512.92%
SpS5.03
BVpS4.01
TBVpS4.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -5.16%
ROE -38.04%
ROCE 1.01%
ROIC 0.71%
ROICexc 0.73%
ROICexgc 0.73%
OM 4.65%
PM (TTM) N/A
GM 17.76%
FCFM 54.45%
ROA(3y)-2.47%
ROA(5y)-0.91%
ROE(3y)-16.73%
ROE(5y)-6.94%
ROIC(3y)1.9%
ROIC(5y)2.12%
ROICexc(3y)1.95%
ROICexc(5y)2.2%
ROICexgc(3y)1.95%
ROICexgc(5y)2.2%
ROCE(3y)2.69%
ROCE(5y)3.01%
ROICexgc growth 3Y-26.63%
ROICexgc growth 5Y-23.14%
ROICexc growth 3Y-26.63%
ROICexc growth 5Y-23.14%
OM growth 3Y-20.54%
OM growth 5Y-12.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.05%
GM growth 5Y-6.76%
F-Score5
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 4.8
Debt/FCF 9.27
Debt/EBITDA 71.8
Cap/Depr 0.86%
Cap/Sales 0.01%
Interest Coverage 0.22
Cash Conversion 1020.6%
Profit Quality N/A
Current Ratio 4.49
Quick Ratio 0.19
Altman-Z 1.02
F-Score5
WACC3.36%
ROIC/WACC0.21
Cap/Depr(3y)14.01%
Cap/Depr(5y)16.5%
Cap/Sales(3y)0.08%
Cap/Sales(5y)0.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.45%
EPS Next Y48.11%
EPS Next 2Y41.51%
EPS Next 3Y26.7%
EPS Next 5Y15.63%
Revenue 1Y (TTM)43.83%
Revenue growth 3Y-3.3%
Revenue growth 5Y-2.61%
Sales Q2Q%8.18%
Revenue Next Year-29.11%
Revenue Next 2Y8.43%
Revenue Next 3Y10.31%
Revenue Next 5Y9.38%
EBIT growth 1Y-44.77%
EBIT growth 3Y-23.16%
EBIT growth 5Y-14.59%
EBIT Next Year118.69%
EBIT Next 3Y38.46%
EBIT Next 5Y23.46%
FCF growth 1Y224.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y225.46%
OCF growth 3YN/A
OCF growth 5YN/A

NORATIS AG / NUVA.DE Fundamental Analysis FAQ

What is the fundamental rating for NUVA stock?

ChartMill assigns a fundamental rating of 3 / 10 to NUVA.DE.


What is the valuation status for NUVA stock?

ChartMill assigns a valuation rating of 5 / 10 to NORATIS AG (NUVA.DE). This can be considered as Fairly Valued.


How profitable is NORATIS AG (NUVA.DE) stock?

NORATIS AG (NUVA.DE) has a profitability rating of 2 / 10.